GUIA DE SEGUIMIENTO FARMACOTERAPEUTICO SOBRE DIABETES PDF

que la mortalidad a largo plazo esté relacionada sobre todo con la recidiva de la enfermedad actuaciones en una guía de seguimiento del paciente trasplantado. . documento recoge recomendaciones farmacoterapéuticas, de autocuidado, de . de las guías. • Algunos pacientes pueden comenzar con una diabetes de. Efectividad del seguimiento farmacoterapéutico en diabéticos tipo 2 clínica, se obtuvo información sobre medicamentos antidiabéticos utilizados, dosis, .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Objetivos: Realizar un seguimiento farmacoterapéutico y educar a pacientes conocimiento sobre la menopausia y la THR en pacientes menopaúsicas. Keywords: Hormone . ministerial que generará Guías Clínicas y tratará . stock de éste por el laboratorio que los produce. Diabetes. 38%. Depresión.

Author: Gok Kajora
Country: Barbados
Language: English (Spanish)
Genre: Photos
Published (Last): 17 September 2007
Pages: 370
PDF File Size: 20.60 Mb
ePub File Size: 8.5 Mb
ISBN: 796-6-53367-321-2
Downloads: 96306
Price: Free* [*Free Regsitration Required]
Uploader: Kazibei

Increased effectiveness of the antidiabetic therapy was not demonstrated in patients intervened with pharmacotherapeutical monitoring, but we did obtain a reduction in healthcare costs. NOMs can be classified into three types: Causes of NOM identified in the study patients can be seen in Table 3. There is evidence in different countries around the world that the lack of NOM detection and solution may lead to additional costs in the healthcare system.

Seguimiento farmacoterapéutico en pacientes con insuficiencia renal crónica

The NOMs with the highest prevalence were those for Non-Quantitative Insecurity; therefore, these represent farmacoterapeutiico highly prevalent problem.

The parameters were type-1 error at 0.

Physicians from EPSs were informed on the objectives and benefits of the pharmaceutical monitoring study and of the importance of their active participation in the program to offer complete patient care.

Upon changes in medication, a new condition status was established, which also evaluated the acceptance or non-acceptance of the physician’s pharmaceutical recommendations. Solution of negative outcomes associated with medication. It must be stated that the pharmacotherapeutic monitoring was carried out by the drug dispensing entity and not by the healthcare provider, for this reason farmwcoterapeutico cost was not charged to the direct costs of patient healthcare.

Stemer G, Lemmens G. The study was conveniently conducted in these cities because there was trained personnel for said purpose.

  BUDERUS LOGALUX SU 160 PDF

Universidad de Granada Grupo de Investigación en Atención Farmacéutica [WorldCat Identities]

Poor control of patients with type-2 diabetes mellitus is a problem affecting all nations. A descriptive analysis was performed of the cost variable for each of the EPSs and in each of the groups. There is also evidence in that the results of pharmaceutical care may lead to reduced utilization of healthcare services and to a lower number of medications prescribed Los pacientes de ambos grupos tomaban en promedio 6.

Necessity NOMs, when patients are not receiving an adequate treatment for their condition, and the other cause is that the health problems of patients are not receiving treatment; Effectiveness NOMs, when the treatment does not meet the therapeutical objectives, based on the dose administered; and Safety NOMs, identified when health problems develop as a consequence of drug therapy, which can be dose-dependent or not.

Given that different studies have not been able to show the efficacy of pharmacotherapeutic monitoring to better control the disease and even reduce healthcare costs, we suggest the need for said intervention to aid in optimizing the benefits in healthcare services for patients with chronic treatments.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica

Conclusion The NOMs with the highest prevalence were those for Non-Quantitative Insecurity; therefore, these represent a highly prevalent problem. Materials and method The design was Quasi-experimental, so that variables would not be intentionally modified, but interventions could be conducted that modified the final out-come of pharmacological treatment in patients.

Pharmacotherapeutic records were the primary source of information and the secondary sources were the clinical histories, the status of the condition, records of medications dispensed by quantities and costs, along with the data base from the EPS services with the records of services rendered to their users, appointments with their treating physicians, authorizations for paraclinical exams requested by the physicians, among others.

A quasi-experimental study was conducted, with a descriptive and retrospective design, in 47 hospitalized patients diagnosed with chronic kidney disease in a high-complexity clinic.

Suggested interventions in pharmacotherapeutic monitoring, to correct this finding, may greatly benefit patients, possibly diminishing morbidity and mortality because of cardiocerebrovascular events associated to the use of said antiplatelet drug Mean age was Of these 6 non-accepted interventions, 3 health problems were not solved, 12 dose readjustments were conducted, with cefepime as the drug with the highest number of dose adjustments; most patients were in Stage III and V of CKD, and its main cause was hypertension and Diabetes Mellitus II.

  FAIRBAIRN MANUAL KNIFE FIGHTING PDF

Diabetes mellitus; Glucosylated hemoglobin A; Hypoglycemic agents; Pharmaceutical services; Colombia. All these problems were detected and solved, pharmaceutical interventions were conducted verbally and in writing, with the aim of helping to improve the aeguimiento of life of patients, and therefore prevent their development.

There was no significant difference found in CKD patients regarding gender; that is to say, male patients are at the same risk of developing it as female patients. Participaron pacientes, 64 intervenidos y 79 controles, con predominio de mujeres It is a useful diabetess for contributing to the adequate use of medications and guaranteeing their safe, effective, and economic use.

frmacoterapeutico The patients in both groups were taking an average farmacotera;eutico 6. The loss of Universidad de Deusto; NOM are classified into problems of necessity, effectiveness, and safety; necessity NOM include untreated health problems and the effects of unnecessary medications, effectiveness NOM include the quantified and non-quantified ineffectiveness, and safety NOM include quantified and non-quantified lack of safety 9 On the other hand, there was an increase in the haemoglobin levels in the optimal group.

Discussion There was no significant difference found in CKD patients regarding gender; that is to say, male patients are at the same risk of developing it as female patients. Diabetes trends in Latin America. Giua developed nations as in developing nations, effectiveness of the therapy measured by controlling HbA1c figures ranges between In Barranquilla, the prevalence of CKD is of approximately 46 persons perinhabitants 1.